Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Delta Air Lines Analysts Boost Their Forecasts After Upbeat Earnings

Published 11/04/2024, 14:26
Updated 11/04/2024, 15:40
© Reuters.  Delta Air Lines Analysts Boost Their Forecasts After Upbeat Earnings

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

Delta Air Lines, Inc. (NYSE: DAL) reported better-than-expected first-quarter earnings.

Delta reported a first-quarter 2024 operating revenue growth of 8% year-over-year to $13.748 billion and adjusted operating revenue of $12.563 billion (+6% YoY), beating the consensus of $12.57 billion. Adjusted EPS was 45 cents, above the consensus of 36 cents, according to data from Benzinga Pro.

“We expect to repay at least $4 billion of debt this year and are on track to improve full year leverage. Our commitment to strengthening the balance sheet was recognized this quarter with positive outlook updates from Moody’s and Fitch, marking our continued progress towards an investment grade rating,” commented Dan Janki, Delta’s chief financial officer.

On a non-GAAP basis, Delta expects second-quarter revenue growth of 5%-7%, EPS of $2.20 – $2.50 versus $2.25 estimate, and operating margin of 14%-15%. On a non-GAAP basis, DAL expects 2024 EPS of $6-$7 versus the $6.46 estimate, free cash flow of $3 billion-$4 billion, and Adjusted Debt to EBITDAR of 2x – 3x.

Delta Air shares fell 2.3% to close at $46.24 on Wednesday.

These analysts made changes to their price targets on Delta Air following earnings announcement.

  • Deutsche Bank raised the price target on Delta Air from $50 to $60. Deutsche Bank analyst Michael Linenberg maintained a Buy rating.
  • B of A Securities boosted the price target on Delta Air from $53 to $55. B of A Securities analyst Andrew Didora maintained a Buy rating.
  • Susquehanna increased the price target on Delta Air from $54 to $55. Susquehanna analyst Christopher Stathoulopoulos maintained a Positive rating.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Read This Next: Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks With Over 3% Dividend Yields

Latest Ratings for DAL

Jan 2022BerenbergUpgradesHoldBuy
Jan 2022Argus ResearchUpgradesHoldBuy
Jan 2022BarclaysMaintainsEqual-Weight

View the Latest Analyst Ratings

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.